Cobblestone Brands Expands Portfolio with Acquisition of Knappogue Castle and Clontarf Irish Whiskeys

Jul 29, 2025- by CMI| Category : Food and Beverages1 min read
Cobblestone Brands Expands Portfolio with Acquisition of Knappogue Castle and Clontarf Irish Whiskeys

Cobblestone Brands has purchased Knappogue Castle and Clontarf Irish whiskeys from Pernod Ricard-owned Irish Distillers.

The transaction is a major milestone for Cobblestone as it seeks to reinforce its position in the expanding Irish whiskey market. It also testifies to Cobblestone's dedication to investing in heritage brands in the spirits industry.

As per Coherent Market Insights, the Irish whiskey industry will develop a 7.3% CAGR over the forecast period of 2025-2032. Market size in 2025 is USD 5.47 Bn and is expected to increase by approximately USD 8.95 Bn in 2032. Market size is prompted by increased popularity among young consumers and penetration into new markets.

Irish Distillers CEO, Nodjame Fouad, said the divestment was part of the company's strategy to focus on its core portfolio of Irish whiskeys. He was positive about Cobblestone's potential to increase the market profile of Knappogue Castle and Clontarf.

Matheson brokered the sale of Clontarf and Knappogue Irish whiskey brands, and its advisory team, coordinated by Corporate M&A partners Sandie Lord and George Brady, comprised corporate associate Patrick Foley and trainee Killian Farrelly.

Lord underscored the importance of the sale: "We are pleased to have advised our long-time client on this sale. The sale of these iconic brands illustrates the appeal of the drinks industry, with the Irish Distillers brands again leading the global Irish whiskey renaissance."

Earlier in the month of July 2025, Pernod Ricard revealed the offloading of its Indian business of Imperial Blue. The divestment was one of the key plans to focus on premium offerings and improve profitability in major markets.

Source:

NewsPlatform:SoraNews24

Share this story

About the author

Ravina Pandya

is a seasoned content writer with over 3.5 years of hands-on experience across various writing formats, including news articles, blog posts, press releases, and informational content. Her expertise lies in producing high-quality, informative content tailored to meet the specific needs of diverse industries, such as Biotechnology, Clinical Diagnostic, Healthcare IT, advanced material, and Medical Devices. She has a deep understanding of how to craft engaging narratives that align with industry trends, helping businesses enhance their online presence and communicate effectively with their audiences.

What sets Ravina apart is her keen eye for detail and her passion for storytelling. She approaches every piece of content with the intent to make it not just informative but also impactful, ensuring that it resonates with the audience on a deeper level. With a reputation for producing timely and relevant articles, she has made significant contributions to the field by helping companies effectively communicate their brand message through engaging, clear, and creative writing. As an advocate for clarity in communication, she continues to explore new ways of refining her craft while remaining at the forefront of content trends.